Predicting Hemagglutinin MHC-II Ligand Analogues in Anti-TNFα Biologics: Implications for Immunogenicity of Pharmaceutical Proteins

PLoS ONE - United States
doi 10.1371/journal.pone.0135451
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Outer Membrane Proteins Preferentially Load MHC Class II Peptides: Implications for a Chlamydia Trachomatis T Cell Vaccine

Vaccine
Molecular MedicinePublic HealthVeterinaryMicrobiology EnvironmentalImmunologyInfectious DiseasesOccupational Health
2015English

Model for the Peptide-Free Conformation of Class II MHC Proteins

PLoS ONE
Multidisciplinary
2008English

Clinical Reactivity and Immunogenicity of Hemagglutinin Influenza Vaccine

Archives of Virology
MedicineVirology
1972English

Misfolded Proteins Complexed With MHC Class II Molecules Are Targets for Autoantibodies

Japanese Journal of Clinical Immunology
2016English

Predicting Treatment Success With Biologics in Psoriasis

British Journal of Dermatology
DermatologyMedicine
2019English

IterTunnel; A Method for Predicting and Evaluating Ligand EgressTunnels in Proteins With Buried Active Sites

Journal of Cheminformatics
Computer GraphicsInformation SciencesLibraryTheoretical ChemistryComputer Science ApplicationsComputer-Aided DesignPhysical
2014English

Safety and Immunogenicity of a Baculovirus-Expressed Hemagglutinin Influenza Vaccine

JAMA - Journal of the American Medical Association
Medicine
2007English

Challenges Predicting Ligand-Receptor Interactions of Promiscuous Proteins: The Nuclear Receptor PXR

PLoS Computational Biology
Molecular NeuroscienceEvolutionEcologyGeneticsBehaviorMolecular BiologySystematicsSimulationCellularComputational TheoryMathematicsModeling
2009English

Discovery of Gorilla MHC-C Expressing C1 Ligand for KIR

Immunogenetics
ImmunologyGenetics
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy